Experimental model for myelodysplastic syndromes uncovers genetic alterations to improve characterization

Updated on: July 12,2025

Experimental model for myelodysplastic syndromes uncovers genetic alterations to improve characterization

Updated on:July 12,2025

Media visibility and costs of new medicines under examination—what does the media highlight?

Updated on: September 28,2025

Media visibility and costs of new medicines under examination—what does the media highlight?

Updated on:September 28,2025

All generic drugs are not equal, study finds

Updated on: March 27,2025

All generic drugs are not equal, study finds

Updated on:March 27,2025

Drug combination shows promise for early treatment after myocardial infarction

Updated on: July 10,2025

Drug combination shows promise for early treatment after myocardial infarction

Updated on:July 10,2025

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on: September 30,2025

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on:September 30,2025

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

Updated on: October 06,2025

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

Updated on:October 06,2025

Combined oral contraceptive use among people with migraine with aura persists, despite cautions

byBoston UniversityCredit: Pixabay/CC0 Public DomainCurrent medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migrai

Updated on: December 27,2025

Combined oral contraceptive use among people with migraine with aura persists, despite cautions

byBoston UniversityCredit: Pixabay/CC0 Public DomainCurrent medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migrai

Updated on:December 27,2025

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Updated on: July 16,2025

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Updated on:July 16,2025

Vitamin D can increase likelihood that breast cancer will disappear with chemotherapy

Updated on: July 11,2025

Vitamin D can increase likelihood that breast cancer will disappear with chemotherapy

Updated on:July 11,2025

Colon cancer considered cured after six years when relapse risk falls below 0.5%

Updated on: November 04,2025

Colon cancer considered cured after six years when relapse risk falls below 0.5%

Updated on:November 04,2025